CSL Behring Presents Results for Garadacimab as Preventive Treatment in Hereditary Angioedema

HATTERSHEIM, Germany Investigational Monoclonal Antibody Granted U.S. FDA Orphan Drug Designation

Five Tips for Wearing a Face Mask

Because of COVID-19, face coverings are now encouraged – and sometimes required – so how can you wear one most comfortably?

CSL Behring’s Global Role in Battling COVID-19

Here is how CSL Behring is working around the world with academia, industry and governments to combat the novel coronavirus C…

Saving Lives by Donating Plasma

CSL Behring employees are responding to need by rolling up their sleeves for rare disease patients.

Listen: Why We Do Clinical Trials

Podcast explores why clinical trials are so essential to advancements for patients.

CSL Behring and Seattle Children’s Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases

SEATTLE and KING of PRUSSIA, Pa. Initially, the alliance will develop treatment options for patients with two rare, life-t…

Two Grants Awarded In Transplant Medicine

Work in this transformative area of medicine continues amid the COVID-19 pandemic.

Take the UNICEF Quiz About COVID-19

Global children’s charity, physicians and scientists aim to “spread facts” and fight misinformation.

How to put your best (virtual) foot forward.

With more job interviews happening online because of COVID-19, CSL Behring’s Talent Acquisition team shares best practices fo…

The Fight Is In Us

With a mission to encourage plasma donations, a new campaign finds support from a COVID-19 survivor group, medical research c…

Thermo Fisher Scientific and CSL Enter Strategic Partnership

WALTHAM, Mass. and KING OF PRUSSIA, Penn. Thermo Fisher Scientific Inc. and CSL Limited have entered into a strategic part…

Dr. David Fajgenbaum Takes on COVID-19

University of Pennsylvania research team examines the “cytokine storm” in pursuit of effective treatments.